(Q43759722)

English

Prospective evaluation of colonization with extended-spectrum beta-lactamase (ESBL)-producing enterobacteriaceae among patients at hospital admission and of subsequent colonization with ESBL-producing enterobacteriaceae among patients during hospita

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 November 2017

Prospective evaluation of colonization with extended-spectrum beta-lactamase (ESBL)-producing enterobacteriaceae among patients at hospital admission and of subsequent colonization with ESBL-producing enterobacteriaceae among patients during hospita (English)

1 reference

Europe PubMed Central

26 November 2017

Enterobacteriaceae

0 references

author name string

Reuven Friedmann

1

1 reference

Europe PubMed Central

26 November 2017

David Raveh

2

1 reference

Europe PubMed Central

26 November 2017

Esther Zartzer

3

1 reference

Europe PubMed Central

26 November 2017

Bernard Rudensky

4

1 reference

Europe PubMed Central

26 November 2017

Ellen Broide

5

1 reference

Europe PubMed Central

26 November 2017

Denise Attias

6

1 reference

Europe PubMed Central

26 November 2017

Amos M Yinnon

7

1 reference

Europe PubMed Central

26 November 2017

publication date

1 June 2009

1 reference

Europe PubMed Central

26 November 2017

Infection Control and Hospital Epidemiology

1 reference

Europe PubMed Central

26 November 2017

30

1 reference

Europe PubMed Central

26 November 2017

6

1 reference

Europe PubMed Central

26 November 2017

534-542

1 reference

Europe PubMed Central

26 November 2017

Screening for extended-spectrum beta-lactamase-producing Enterobacteriaceae among high-risk patients and rates of subsequent bacteremia

1 reference

https://api.crossref.org/works/10.1086%2F597505

21 January 2018

Community-acquired extended-spectrum beta-lactamase producers, United States.

1 reference

https://api.crossref.org/works/10.1086%2F597505

21 January 2018

Extended-spectrum beta-lactamases in ambulatory care: a clinical perspective

1 reference

https://api.crossref.org/works/10.1086%2F597505

21 January 2018

Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern

1 reference

https://api.crossref.org/works/10.1086%2F597505

21 January 2018

Clinical significance and impact on mortality of extended-spectrum beta lactamase-producing Enterobacteriaceae isolates in nosocomial bacteremia

1 reference

https://api.crossref.org/works/10.1086%2F597505

21 January 2018

Extended-spectrum beta-lactamases in long-term-care facilities

1 reference

https://api.crossref.org/works/10.1086%2F597505

21 January 2018

Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory.

1 reference

https://api.crossref.org/works/10.1086%2F597505

21 January 2018

In-vitro activity of cefepime and other broad-spectrum antimicrobials against several groups of gram-negative bacilli and Staphylococcus aureus.

1 reference

https://api.crossref.org/works/10.1086%2F597505

21 January 2018

Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes

1 reference

https://api.crossref.org/works/10.1086%2F597505

21 January 2018

Acquisition of multidrug-resistant organisms among hospital patients hospitalized in beds adjacent to critically ill patients.

1 reference

https://api.crossref.org/works/10.1086%2F597505

21 January 2018

Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment

1 reference

https://api.crossref.org/works/10.1086%2F597505

21 January 2018

Extended-spectrum beta-lactamases: a clinical update

1 reference

https://api.crossref.org/works/10.1086%2F597505

21 January 2018

Bacterial resistance: origins, epidemiology, and impact.

1 reference

https://api.crossref.org/works/10.1086%2F597505

21 January 2018

Modification of patients' endogenous bacterial flora during hospitalization in a large teaching hospital in Naples.

1 reference

https://api.crossref.org/works/10.1086%2F597505

21 January 2018

Detection and treatment of antibiotic-resistant bacterial carriage in a surgical intensive care unit: a 6-year prospective survey.

1 reference

https://api.crossref.org/works/10.1086%2F597505

21 January 2018

Epidemiology of multidrug-resistant bacteria in patients with long hospital stays

1 reference

https://api.crossref.org/works/10.1086%2F597505

21 January 2018

Dramatic increase in prevalence of fecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae during nonoutbreak situations in Spain

1 reference

https://api.crossref.org/works/10.1086%2F597505

21 January 2018

The role of nasal carriage in Staphylococcus aureus infections

1 reference

https://api.crossref.org/works/10.1086%2F597505

21 January 2018

Longitudinal surveillance of antibiotic use in the hospital

1 reference

https://api.crossref.org/works/10.1086%2F597505

21 January 2018

Practical guidelines for vancomycin usage, with prospective drug-utilization evaluation

1 reference

https://api.crossref.org/works/10.1086%2F597505

21 January 2018

Prospective drug utilization evaluation of three broad-spectrum antimicrobials: cefepime, piperacillin-tazobactam and meropenem

1 reference

https://api.crossref.org/works/10.1086%2F597505

21 January 2018

Assessment of the clinical significance of production of extended-spectrum beta-lactamases (ESBL) by Enterobacteriaceae

1 reference

https://api.crossref.org/works/10.1086%2F597505

21 January 2018

Antimicrobial susceptibilities of urinary pathogens in a multidisciplinary long-term care facility

1 reference

https://api.crossref.org/works/10.1086%2F597505

21 January 2018

Prospective hospital-wide studies of 505 patients with nosocomial bacteraemia in 1997 and 2002.

1 reference

https://api.crossref.org/works/10.1086%2F597505

21 January 2018

Susceptibility trends in bacteraemias: analyses of 7544 patient-unique bacteraemic episodes spanning 11 years (1990-2000).

1 reference

https://api.crossref.org/works/10.1086%2F597505

21 January 2018

Optimization of empirical antibiotic selection for suspected Gram-negative bacteraemia in the emergency department

1 reference

https://api.crossref.org/works/10.1086%2F597505

21 January 2018

Clinical and demographic characteristics of elderly patients hospitalised in an internal medicine department in Israel.

1 reference

https://api.crossref.org/works/10.1086%2F597505

21 January 2018

Demographic and clinical characteristics of patients admitted to medical departments.

1 reference

https://api.crossref.org/works/10.1086%2F597505

21 January 2018

Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients

1 reference

https://api.crossref.org/works/10.1086%2F597505

21 January 2018

Extended-spectrum beta-lactamase (ESBL)-producing enterobacteria: factors associated with infection in the community setting, Auckland, New Zealand.

1 reference

https://api.crossref.org/works/10.1086%2F597505

21 January 2018

Risk factors for faecal carriage of Klebsiella pneumoniae producing extended spectrum β-lactamase (ESBL-KP) in the intensive care unit

1 reference

https://api.crossref.org/works/10.1086%2F597505

21 January 2018

Identifiers

1 reference

Europe PubMed Central

26 November 2017

1 reference

Europe PubMed Central

26 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43759722&oldid=2103097611"